Vascular Imaging Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique (MRI, CT scan, Ultrasound, Nuclear Imaging, X Ray), By Procedure (Coronary Angiography, Peripheral Angiography, Vascular Ultrasound, Cerebral Angiography, Others), By End-User (Hospitals & Clinics, Ambulatory care Centers, Others) Region and Competition, 2020-2030F

Market Overview

The Global Vascular Imaging Systems Market, valued at USD 6.32 Billion in 2024, is projected to experience a CAGR of 3.61% to reach USD 7.82 Billion by 2030. Vascular imaging systems comprise specialized medical devices utilizing various modalities, including ultrasound, computed tomography, magnetic resonance imaging, and angiography, to visualize blood vessels, diagnose vascular pathologies, and guide interventional procedures. The market growth for these systems is primarily propelled by the escalating global incidence of cardiovascular diseases and an expanding geriatric demographic, necessitating advanced diagnostic capabilities. Additionally, continuous technological advancements, such as improved image resolution and artificial intelligence integration, serve as key market drivers.

According to MedTech Europe, over 15,900 patent applications were filed with the European Patent Office in the medical technology field during 2023, highlighting sustained innovation across the industry. Nevertheless, the substantial capital expenditure associated with the acquisition and maintenance of these complex systems poses a notable challenge that could constrain market expansion.

Key Market Drivers

The rising global prevalence of vascular and cardiovascular diseases significantly drives the demand for advanced imaging systems. Conditions such as coronary artery disease, peripheral artery disease, and stroke necessitate precise and timely diagnosis to enable effective treatment planning and intervention. According to the World Health Organization, in July 2025, an estimated 19.8 million people died from cardiovascular diseases in 2022, accounting for approximately 32% of all global deaths. This substantial burden of disease directly compels healthcare systems worldwide to adopt sophisticated vascular imaging technologies capable of providing detailed visualization of blood vessels and detecting pathologies early, thereby accelerating the utilization of modalities like ultrasound, computed tomography, and magnetic resonance imaging for accurate assessment and management of patient conditions.

Concurrently, the aging global population represents another fundamental catalyst for the vascular imaging systems market. As individuals age, their inherent susceptibility to various vascular pathologies including atherosclerosis, aneurysms, and venous insufficiency increases considerably. According to the World Health Organization, in February 2025, the number of people aged 60 and older worldwide is projected to increase from 1.1 billion in 2023 to 1.4 billion by 2030. This demographic shift creates an expanding patient demographic requiring regular screening, diagnosis, and monitoring of vascular health. Furthermore, the broader medical technology sector, which encompasses vascular imaging, continues to demonstrate robust investment. According to the European Federation of Pharmaceutical Industries and Associations, in November 2024, health industries invested approximately €258.1 billion in research and development in 2023, underscoring the ongoing commitment to advancing diagnostic and therapeutic solutions within the healthcare landscape.

Download Free Sample Report

Key Market Challenges

The substantial capital expenditure required for acquiring and maintaining advanced vascular imaging systems presents a significant barrier to market expansion. The high initial investment for modalities like computed tomography, magnetic resonance imaging, and angiography units limits their adoption, particularly by smaller healthcare facilities or those operating within constrained budgets. This financial burden extends beyond procurement to include ongoing maintenance, specialized infrastructure, and software upgrades, thereby increasing the total cost of ownership.

This challenge directly impedes the modernization and expansion of diagnostic capabilities. According to COCIR, the European trade association for medical imaging, in 2023, a quarter of CT and MRI units in Europe were more than 10 years old, along with a third of X-ray mammography and interventional units. Such aging equipment indicates delayed replacement cycles, directly impacting the availability of the latest vascular imaging technologies for patient care and hindering market growth for new system installations. The ongoing fiscal pressures on healthcare providers further exacerbate this situation, prioritizing immediate operational needs over costly capital equipment upgrades.

Key Market Trends

Two significant trends currently shaping the Global Vascular Imaging Systems Market are the integration of Artificial Intelligence in image analysis and the expansion of telemedicine for remote vascular diagnostics. These trends are distinct from market drivers focused on disease prevalence or demographic shifts, instead emphasizing technological and service delivery innovations.

The integration of Artificial Intelligence (AI) in image analysis is fundamentally enhancing diagnostic precision and operational efficiency within vascular imaging. AI algorithms accelerate and improve the accuracy of complex imaging data interpretation, supporting the timely identification of vascular pathologies. The Radiological Society of North America reported in October 2023 that 75% of over 500 FDA-cleared AI algorithms targeted radiology, signifying AI’s vital role in diagnostics. This advancement enables automated measurements and the detection of subtle abnormalities, assisting clinicians in more precise decision-making. Siemens Healthineers, in August 2024, received FDA clearance for its AI-powered Acuson Origin cardiovascular ultrasound system, capable of over 5,000 automated measurements and cardiac structure recognition, directly improving diagnostic accuracy and workflow for vascular conditions.

The expansion of telemedicine for remote vascular diagnostics significantly broadens access to specialized imaging services, particularly benefiting rural and underserved areas. This trend utilizes digital communication technologies for remote consultations, image review, and tele-mentored scanning, reducing patient travel burdens and optimizing expert resource allocation. MedTech Europe, in its September 2024 "A Call to Action 2024–2029" report, highlighted that telemedicine improves healthcare efficiency and bridges existing care gaps. These capabilities are crucial for continuous follow-up and early disease detection in populations lacking immediate access to advanced local vascular imaging. DeepHealth, in August 2025, obtained FDA 510(k) clearance for its TechLive remote scanning solution, which reduced MRI room closure hours by 42% in a Q2 2025 pilot at 64 RadNet sites compared to the prior year, improving patient access to complex imaging through remote expert supervision.

Segmental Insights

The Hospitals & Clinics segment is experiencing rapid growth within the Global Vascular Imaging Systems Market due to several converging factors. Hospitals, with their comprehensive diagnostic and interventional capabilities, serve a large patient base affected by the increasing global prevalence of cardiovascular diseases and an expanding geriatric population, both of which necessitate frequent vascular imaging. Furthermore, continuous technological advancements, including improved resolution, faster scanning, and the integration of artificial intelligence into imaging systems, drive adoption in these facilities. Hospitals are also equipped with the financial capacity and established infrastructure to invest in and utilize these advanced modalities, supporting timely diagnosis and intervention for complex vascular conditions.

Regional Insights

North America is the dominant region in the Global Vascular Imaging Systems Market due to several interconnected factors. The region benefits from a highly developed healthcare infrastructure and significant healthcare expenditure, which facilitate the widespread adoption of advanced medical technologies. There is a high prevalence of cardiovascular and peripheral vascular diseases in North America, driving consistent demand for sophisticated diagnostic tools. Additionally, supportive regulatory frameworks, such as those from the U. S. Food and Drug Administration (FDA), encourage innovation and the early market entry of new vascular imaging systems. Furthermore, favorable reimbursement policies for vascular diagnostic procedures significantly contribute to the region's market leadership. North America leads the Global Vascular Imaging Systems Market, primarily driven by its advanced healthcare infrastructure and substantial healthcare expenditure. The region exhibits a high prevalence of cardiovascular and peripheral vascular diseases, necessitating a strong demand for diagnostic and interventional imaging solutions. North America's dominance is further supported by the early adoption of advanced medical technologies and the presence of a robust regulatory environment that facilitates innovation. Favorable reimbursement policies for vascular diagnostic procedures also play a crucial role in expanding market penetration and system utilization across hospitals and diagnostic centers.

Recent Developments

• In September 2025, Conavi Medical submitted its next-generation Novasight Hybrid™ intravascular imaging system to the U.S. FDA for 510(k) clearance, a key development in the Global Vascular Imaging Systems Market. This system uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single, integrated device. The dual-modality approach aims to provide cardiologists with a comprehensive view of coronary arteries, facilitating more precise diagnosis and treatment of cardiovascular disease. Key advancements included enhanced IVUS and OCT image quality, alongside a simplified user interface designed to improve cath lab workflows.

• In August 2025, GE HealthCare launched its Vivid Pioneer, an advanced AI-powered cardiovascular ultrasound system, marking a significant new product introduction to the Global Vascular Imaging Systems Market. This system was designed to enhance diagnostic confidence and streamline workflows through exceptional imaging in 2D, 4D, and color flow. The Vivid Pioneer integrated the next-generation cSound Pioneer architecture and sophisticated probe technology, including 4Vc-D and 6Sc-D probes, to visualize fine anatomical structures. Furthermore, its AI algorithms automate measurements and accelerate various cardiovascular assessments, such as AI Cardiac Auto Doppler and Easy AFI, thereby improving efficiency for clinicians.

• In June 2024, Royal Philips introduced its Image Guided Therapy Mobile C-arm System 9000 – Zenition 90 Motorized, a new product launch impacting the Global Vascular Imaging Systems Market. This mobile C-arm was specifically engineered to address complex vascular needs, in addition to supporting a range of other clinical procedures. The system enhanced control and efficiency through automated workflows, leveraging innovations previously seen in Philips' Azurion platform. It provided high-quality imaging for challenging interventions and allowed clinicians to manage the device from the patient's bedside, offering increased flexibility and autonomy.

• In February 2024, UltraSight announced a collaboration with SELVAS Healthcare, a significant partnership in the Global Vascular Imaging Systems Market. The companies formed a joint venture to develop and commercialize UltraSight's real-time AI guidance technology for cardiac ultrasound in Asia. This initiative aimed to navigate the regulatory processes for approvals, with a vision for subsequent commercialization and distribution across Korea and the broader Southeast Asian market. The AI-powered software integrates with point-of-care ultrasound devices, enabling medical professionals to acquire diagnostic-quality cardiac ultrasound images, thereby expanding access to timely cardiac diagnoses.

Key Market Players

• Siemens Healthineers AG
• GE Healthcare
• Koninklijke Philips N.V.
• Hitachi Medical Corporation
• Samsung Medison Co., Ltd.
• Shimadzu Medical Systems
• Hologic Inc.
• Abbott Laboratories Inc.
• OrthoScan, Inc.
• Canon Medical Systems Corporation

Report Scope:

In this report, the Global Vascular Imaging Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vascular Imaging Systems Market, By Technique:

o   MRI

o   CT scan

o   Ultrasound

o   Nuclear Imaging

o   X Ray

• Vascular Imaging Systems Market, By Procedure:

o   Coronary Angiography

o   Peripheral Angiography

o   Vascular Ultrasound

o   Cerebral Angiography

o   Others

• Vascular Imaging Systems Market, By End User:

o   Hospitals & clinics

o   Ambulatory Surgical Services

o   Others

• Vascular Imaging Systems Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Vascular Imaging Systems Market.

Available Customizations:

Global Vascular Imaging Systems Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Vascular Imaging Systems Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]